LV versus ip administration of chimeric monoclonal antibody MOv18 (c-MOv18) in patiemts with ovarian cancer

RHM Verheijen, P. Kenemans, C.F.M. Molthoff, W. den Hollander, A.C. van Hof, M.R. Buist, J.B Vermorken, J.C. Roos

Research output: Contribution to conferenceAbstractOther research output

Original languageEnglish
Publication statusPublished - 1994
EventISOBM - Groningen, Netherlands
Duration: 28 Mar 1994 → …

Conference

ConferenceISOBM
Country/TerritoryNetherlands
CityGroningen
Period28/03/94 → …

Cite this